Annual Accounts Payable
$666.00 K
+$150.00 K+29.07%
December 1, 2024
Summary
- As of March 10, 2025, CMMB annual accounts payable is $666.00 thousand, with the most recent change of +$150.00 thousand (+29.07%) on December 1, 2024.
- During the last 3 years, CMMB annual accounts payable has fallen by -$670.00 thousand (-50.15%).
- CMMB annual accounts payable is now -60.55% below its all-time high of $1.69 million, reached on December 31, 2022.
Performance
CMMB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$666.00 K
+$280.00 K+72.54%
December 1, 2024
Summary
- As of March 10, 2025, CMMB quarterly accounts payable is $666.00 thousand, with the most recent change of +$280.00 thousand (+72.54%) on December 1, 2024.
- Over the past year, CMMB quarterly accounts payable has stayed the same.
- CMMB quarterly accounts payable is now -71.62% below its all-time high of $2.35 million, reached on June 30, 2023.
Performance
CMMB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CMMB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.1% | 0.0% |
| 3 y3 years | -50.1% | 0.0% |
| 5 y5 years | +616.1% | 0.0% |
CMMB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.5% | +29.1% | -71.6% | +72.5% |
| 5 y | 5-year | -60.5% | +616.1% | -71.6% | +616.1% |
| alltime | all time | -60.5% | +616.1% | -71.6% | +616.1% |
Chemomab Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $666.00 K(+29.1%) | $666.00 K(+72.5%) |
| Sep 2024 | - | $386.00 K(-65.3%) |
| Jun 2024 | - | $1.11 M(+111.2%) |
| Mar 2024 | - | $527.00 K(+2.1%) |
| Dec 2023 | $516.00 K(-69.4%) | $516.00 K(-78.0%) |
| Jun 2023 | - | $2.35 M(+5.9%) |
| Mar 2023 | - | $2.22 M(+31.3%) |
| Dec 2022 | $1.69 M | $1.69 M(+35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.25 M(-13.0%) |
| Jun 2022 | - | $1.43 M(-3.6%) |
| Mar 2022 | - | $1.49 M(+11.3%) |
| Dec 2021 | $1.34 M(+1336.6%) | $1.34 M(+177.8%) |
| Sep 2021 | - | $481.00 K(+1.9%) |
| Jun 2021 | - | $472.00 K(-77.3%) |
| Mar 2021 | - | $2.08 M(+2139.8%) |
| Dec 2020 | $93.00 K | $93.00 K |
FAQ
- What is Chemomab Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual accounts payable year-on-year change?
- What is Chemomab Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly accounts payable year-on-year change?
What is Chemomab Therapeutics annual accounts payable?
The current annual accounts payable of CMMB is $666.00 K
What is the all time high annual accounts payable for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual accounts payable is $1.69 M
What is Chemomab Therapeutics annual accounts payable year-on-year change?
Over the past year, CMMB annual accounts payable has changed by +$150.00 K (+29.07%)
What is Chemomab Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CMMB is $666.00 K
What is the all time high quarterly accounts payable for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly accounts payable is $2.35 M
What is Chemomab Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CMMB quarterly accounts payable has changed by $0.00 (0.00%)